Found: 34
Select item for more details and to access through your institution.
Treating Rosai–Dorfman disease and RAS‐associated autoimmune leucoproliferative disorder with malignant transformation.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 667, doi. 10.1111/bjh.17258
- By:
- Publication type:
- Article
Lenalidomide plus rituximab (R<sup>2</sup>) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 874, doi. 10.1111/bjh.15843
- By:
- Publication type:
- Article
Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 4, p. 583, doi. 10.1111/bjh.14820
- By:
- Publication type:
- Article
Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 851, doi. 10.1111/bjh.14267
- By:
- Publication type:
- Article
Dose adjusted- EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 503, doi. 10.1111/bjh.14226
- By:
- Publication type:
- Article
Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 3, p. 488, doi. 10.1111/bjh.14902
- By:
- Publication type:
- Article
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 5, p. 750, doi. 10.1111/bjh.14477
- By:
- Publication type:
- Article
Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 3, p. 531, doi. 10.1111/bjh.13863
- By:
- Publication type:
- Article
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 2, p. 290, doi. 10.1111/bjh.14237
- By:
- Publication type:
- Article
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 80, doi. 10.1111/bjh.13796
- By:
- Publication type:
- Article
Phase II study of HCVIDD/ MA in patients with newly diagnosed peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 509, doi. 10.1111/bjh.13628
- By:
- Publication type:
- Article
Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 1, p. 138, doi. 10.1111/bjh.12326
- By:
- Publication type:
- Article
Dose-Related Safety and Immunogenicity of Baculovirus-Expressed Trivalent Influenza Vaccine: A Double-Blind, Controlled Trial in Adult Patients with Non-Hodgkin B Cell Lymphoma.
- Published in:
- Journal of Infectious Diseases, 2006, v. 194, n. 10, p. 1394, doi. 10.1086/508493
- By:
- Publication type:
- Article
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 99, doi. 10.1016/j.clml.2012.11.002
- By:
- Publication type:
- Article
Phase 2 Study of Gemcitabine in Combination With Rituximab in Patients With Recurrent or Refractory Hodgkin Lymphoma.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 4, p. 831, doi. 10.1002/cncr.23237
- By:
- Publication type:
- Article
Experience with heat shock protein‐peptide complex 96 vaccine therapy in patients with indolent non‐Hodgkin lymphomaPresented in part at the 39th annual meeting of the American Society of Clinical Oncology, May 31, 2003‐June 3, 2003, Chicago, Illinois.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 1, p. 77, doi. 10.1002/cncr.22389
- By:
- Publication type:
- Article
Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 3, p. 586, doi. 10.1002/cncr.11096
- By:
- Publication type:
- Article
Hepatitis B Virus Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 8, p. 610, doi. 10.1016/j.clml.2023.04.006
- By:
- Publication type:
- Article
Rosai-Dorfman Disease: The MD Anderson Cancer Center Experience.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Frontline antibiotic therapy for early‐stage Helicobacter pylori‐negative gastric MALT lymphoma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 6, p. E150, doi. 10.1002/ajh.25447
- By:
- Publication type:
- Article
Recent advances in de novo CD5<sup>+</sup> diffuse large B cell lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 9, p. 798, doi. 10.1002/ajh.23467
- By:
- Publication type:
- Article
Follicular dendritic cell sarcoma: A report of 14 cases and a review of the literature.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 8, p. 725, doi. 10.1002/ajh.20852
- By:
- Publication type:
- Article
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 6, p. 1566, doi. 10.1002/cncr.26433
- By:
- Publication type:
- Article
Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 22, p. 5067, doi. 10.1002/cncr.26121
- By:
- Publication type:
- Article
Marginal Zone Lymphomas.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 18, p. 4291, doi. 10.1002/cncr.25325
- By:
- Publication type:
- Article
Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 1, p. 47, doi. 10.1111/j.1365-2141.2010.08315.x
- By:
- Publication type:
- Article
Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 2, p. 200, doi. 10.1111/j.1365-2141.2010.08228.x
- By:
- Publication type:
- Article
Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma.
- Published in:
- Oncologist, 2017, v. 22, n. 5, p. 549, doi. 10.1634/theoncologist.2016-0328
- By:
- Publication type:
- Article
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 6, p. 876, doi. 10.1002/cncr.35114
- By:
- Publication type:
- Article
The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0191461
- By:
- Publication type:
- Article